Are You in Control of Your Data

Funding Received for Commercialization of Rapid Pathogen Strain Typing System

PathoGenetix™, Inc. has secured $10 million in a Series C financing to fund continued efforts to commercialize its Genome Sequence Scanning™ (GSS™) technology.The GSS technology confirms and identifies microbial DNA in either complex mixtures or isolates, and provides actionable information in five hours. The funding will be used to further develop the first commercial system using the GSS technology, the RESOLUTION™ Microbial Genotyping System. The fully automated RESOLUTION System includes the instrument, bioinformatics software and database, and pathogen-specific assays, and will be commercially available in 2014 for use in food safety testing and foodborne illness outbreak investigations.

The company announced collaborations with the Food and Drug Administration (FDA) in April and the U.S. Department of Agriculture's Agricultural Research Service (USDA-ARS) in September, and is currently conducting a series of customer evaluations with leading food safety testing labs. In June, the company signed an agreement with Applied Maths, NV, to link the RESOLUTION System with the BioNumerics software suite currently in use in thousands of public and private research sites and laboratories around the world.

 


     
Tags: Genotyping, Automation, Pathogen

Date Published: November 4, 2013

Source article link: PathoGenetix™, Inc. » company contact details
Join us on Google+

© 2001 - 2017 Rapid Test Methods Ltd • Please join us on Twitter, Facebook and LinkedIn • RSS Feed